(Q24311390)

2

0 references

J Kukacka

3

0 references

V Vavrova

4

0 references

M Kuzelova

5

0 references

J Ticha

6

0 references

R Prusa

Journal of Clinical Pharmacy and Therapeutics

7

0 references

language of work or name

English

0 references

publication date

August 2008

0 references

published in

0 references

volume

33

0 references

page(s)

409-17

0 references

issue

4

0 references

cites work

Predicting the glomerular filtration rate from serum creatinine, serum cystatin C and the Cockcroft and Gault formula with regard to drug dosage adjustment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

Increased dosage requirements of tobramycin and gentamicin for treating Pseudomonas pneumonia in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

Overestimation of renal function in glucocorticosteroid treated patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

Enzymes in urine as markers of nephrotoxicity of cytostatic agents and aminoglycoside antibiotics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

Automated assay of creatinine in serum as simplified by the use of immobilized enzymes, creatinine deiminase, and glutamate dehydrogenase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

Cystatin for estimation of glomerular filtration rate?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

Limitations of creatinine as a filtration marker in glomerulopathic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

Serum cystatin C is not a better marker of creatinine or digoxin clearance than serum creatinine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

Decreased rate of creatinine production in patients with hepatic disease: implications for estimation of creatinine clearance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

Measured versus estimated creatinine clearance in the elderly as an index of renal function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

Comparative evaluation of iohexol and inulin clearance for glomerular filtration rate determinations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

Urinary N-acetyl-beta-D-glucosaminidase activity in patients with cystic fibrosis on long-term gentamicin inhalation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

Serum cystatin C is a better marker of topotecan clearance than serum creatinine.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

Assessment of the enzymuria resulting from gentamicin alone and combinations of gentamicin with various beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

Protein standardization III: Method optimization basic principles for quantitative determination of human serum proteins on automated instruments based on turbidimetry or nephelometry.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

Use of Serum Creatinine Concentrations to Determine Renal Function1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

Drug disposition in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021

Cystatin C vs creatinine as markers of renal function in patients on digoxin treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00932.X

7 January 2021